Expert Review of Pharmacoeconomics and Outcomes Research

Cuban anticancer vaccine to be clinically tested in Malaysia
pp. 5-9(5)

Costeffectiveness of natalizumab in multiple sclerosis
pp. 11-21(11)
Authors: Holmoy, Trygve; Celius, Elisabeth Gulowsen

Weekend hospitalization and mortality: a critical review
pp. 23-26(4)
Author: Becker, David J

Delays for coronary artery bypass surgery: how long is too long?
pp. 27-32(6)
Authors: Sobolev, Boris; Fradet, Guy

Can inhaled insulin be used for the treatment of diabetes mellitus?
pp. 33-42(10)
Author: de Galan, Bastiaan E

Patient-reported outcomes to evaluate surgery
pp. 43-50(8)
Authors: Avery, Kerry NL; Gujral, Sameer; Blazeby, Jane M

Patient-reported outcomes to evaluate surgery
pp. 43-50(8)
Authors: Avery, Kerry NL; Gujral, Sameer; Blazeby, Jane M

Sex-specific differences in treatment outcomes for patients with HIV and AIDS
pp. 51-63(13)
Authors: Stenehjem, Edward; Shlay, Judith C

Medicaid preferred drug lists: a success story?
pp. 65-71(7)
Author: Murawski, Matthew M

Can pharmacoeconomics and outcomes research contribute to the empowerment of women affected by breast cancer?
pp. 73-79(7)
Authors: Lee, Jessica T; Bridges, John FP; Shockney, Lillie

Social capital, social class and tobacco smoking
pp. 81-89(9)
Author: Lindstrm, Martin

Health-related quality of life: the forgotten outcome in healthcare changes in recent years in Portugal
pp. 91-96(6)
Author: Pimentel, Francisco L